Appendix on transparency rules to the Functional ...
human subjects are publicly registered. The Regulation requires that in future all clinical trials used in support of a clinical trial application are publicly registered in a register providing data to the WHO ICTRP (WHO International Clinical Trials Registry Platform). Older clinical trials
Download Appendix on transparency rules to the Functional ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Ethics in Qualitative Research - Columbia University
www.columbia.eduappropriate ethical principles. Thus, the protection of human subjects or participants in any research study is imperative. Violations of human rights in the name of scientific research have been among the darkest events in history. From 1932-1972 more than 400 African American people who had
ETHICAL CONSIDERATIONS IN RESEARCH
catalogimages.wiley.comThis obligation also entails protecting them from harm, unnec-essary risks, or mental and physical discomfort that may be inherent in the research proce-dure. Research that poses potential harm, risk, or danger to the participant is not allowed, unless the benefit of the research outweighs the risks and full informed consent is given.
Roles & Responsibilities of the Research Team & Sponsors
ccrod.cancer.govAll staff involved in clinical research must adhere to the regulations and understand the guidelines that govern clinical ... human subjects research studies. ... –Protecting the rights, safety , and welfare of study subjects
Guidelines for Responsible Data Management in Scientific ...
ori.hhs.govindividuals who suggest research ideas and/or participate in the research. Some research subjects are expressing a desire for partial ownership or control of research in which they have participated. For instance, in 2 recent court cases, the defense contended that research institutions had improperly benefited in